Review
Diagnosis of giant cell tumor of bone
Pulmonary metastasis of giant cell tumor of bone
Prevalence
Study (Author/year) | Time of follow up | Number of patients | Ratio of pulmonary metastasis |
---|---|---|---|
Errani et al. 2010 [32] | 91 (36-204) months | 349 | 4% |
Kremen et al. 2012 [33] | 0.1-312 months | 230 | 2% |
Takeuchi et al. 2011 [34] | 2-180 months | 110 | 7.5% |
Klenke et al. 2011 [35] | 108 (36-233)months | 118 | 4.2% |
Viswanathan et al. 2010 [36] | 4 months-12 years | 470 | 1.7 |
Balke et al. 2008 [37] | 60 (8-280) months | 214 | 3.3% |
Donthineni et al. 2006 [38] | 18-126months | 51 | 13.7% |
Faisham et al. 2006 [39] | 12-60 months | 20 | 30% |
Dominkus et al. 2006 [30] | 3 months to 11.9 years | 649 | 2.1% |
Prosser et al. 2005 [40] | 70 (24-214) months | 137 | 1.6% |
Su et al. 2004 [41] | 62 (28-138) months | 87 | 1.2% |
Trieb et al. 2001 [42] | 11 (4-43) years | 47 | 0% |
Blackley et al. 1999 [43] | 80 (29-132) months | 59 | 1.7% |
O’Donnell et al. 1994 [44] | 4 (2-10) years | 60 | 0% |
Kay et al. 1994 [45] | 23-120 months | 66 | 9.1% |
Campanacci 1 et al. 987 [1] | 2-44 years | 280 | 2.1% |
McDonald et al. 1986 [46] | 84 (min 24) months | 146 | 3.2% |
Factors related to the pulmonary metastasis of giant cell tumor of bone
Study (Author/year) | Number of patients | Number of patients with pulmonary metastasis | Local recurrence |
---|---|---|---|
Kremen et al. 2012 [33] | 230 | 5 | 28 |
Klenke et al. 2011 [35] | 118 | 5 | 24 |
Errani et al. 2010 [32] | 349 | 14 | 52 |
Prosser et al. 2005 [40] | 137 | 22 | 26 |
Trieb et al. 2001 [42] | 47 | 0 | 11 |
Blackley et al. 1999 [43] | 59 | 10 | 12 |
Kay et al. 1994 [45] | 66 | 6 | 18 |
O’Donnell et al. 1994 [44] | 60 | 0 | 15 |
Viswanathan et al. 2010 [36] | 470 | 8 | 13 of 24 patients with lung metastasis |
Tubb et al. 1992 [48] | 7 of 13 patients with lung metastasis | ||
Goldenberg et al. 1970 [28] | 218 | 6 | 5 of 6 patients with lung metastasis |
Treatment
Surgical treatment
Study (Author/year) | Number of patients | Wide resection | Intralesional curettage | Intralesional curettage + regional burring | Intralesional curettage + PMMA |
---|---|---|---|---|---|
Klenke et al. 2011 [35] | 118 | 5 | N/A | 32 | + phenol + burrin:15 |
Errani et al. 2010 [32] | 349 | 12 | N/A | 18 | |
Balke et al. 2008 [37] | 214 | 0 | 140 | 47 | +phenol: 38 |
Kivioja et al. 2008 [11] | 294 | 12 | 51 | N/A | 22 |
Knochentumoren 2008 [52] | 256 | 2 | 49 | N/A | +phenol:69 |
Malek et al. 2006 [56] | 40 | N/A | N/A | 33 | N/A |
McGough et al. 2005 [57] | 183 | N/A | 46 | N/A | N/A |
Prosser et al. 2005 [40] | 137 | 0 | N/A | N/A | +burring: 21 |
Su et al. 2004 [41] | 87 | 3 | N/A | N/A | +phenol: 18 |
Turcotte et al. 2002 [55] | 186 | 34 | N/A | N/A | +phenol + burring:55 |
Blackley et al. 1999 [43] | 59 | N/A | N/A | 12 | N/A |
Campanacci et al. 1987 [1] | 280 | 0 | 27 | N/A | 8 |
McDonald 1986 [45] | 146 | 7 | N/A | 34 | N/A |
Drug treatment
Prognosis
Study (Author/year) | Number of patients | Cases with pulmonary metastasis | Survivors at the last follow up |
---|---|---|---|
Kremen et al. 2012 [33] | 230 | 5 | 4 |
Takeuchi et al. 2011 [34] | 110 | 8 | 8 |
Errani et al. 2010 [32] | 349 | 14 | 10* |
Klenke et al. 2011 [35] | 118 | 5 | 4 |
Viswanathan et al. 2010 [36] | 470 | 8 | 8 |
Faisham et al. 2006 [39] | 20 | 6 | 5 |
Dominkus et al. 2006 [30] | 649 | 14 | 14 |
Donthineni et al. 2006 [38] | 51 | 7 | 5 |
Kay et al. 1994 [45] | 7 | 7 | 6 |